Aktuelle Neurologie, Inhaltsverzeichnis Aktuelle Neurologie 2015; 42(05): 293-294DOI: 10.1055/s-0035-1552637 Kompetenznetz Multiple Sklerose © Georg Thieme Verlag KG Stuttgart · New YorkAktuelles aus der Forschung T. Menge 1 Zentrum Neurologie und Neuropsychiatrie, LVR-Klinikum, Heinrich-Heine-Universität, Düsseldorf 2 Neurologische Klinik, Heinrich-Heine-Universität, Düsseldorf , G. Meyer zu Hörste 3 Center for Neurologic Diseases, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA› InstitutsangabenArtikel empfehlen Abstract Artikel einzeln kaufen Volltext Referenzen Literatur 1 Moore SM et al. Multiple functional therapeutic effects of the estrogen receptor beta agonist indazole-Cl in a mouse model of multiple sclerosis. Proc Natl Acad Sci USA 2014; 111: 18061-18066 2 Tullius SG et al. NAD+ protects against EAE by regulating CD4+ T-cell differentiation. Nat Commun 2014; 5: 5101 3 Rumble JM et al. Neutrophil-related factors as biomarkers in EAE and MS. J Exp Med 2015; 212: 23-35 4 Stilund M et al. Biomarkers of Inflammation and Axonal Degeneration/Damage in Patients with Newly Diagnosed Multiple Sclerosis: Contributions of the Soluble CD163 CSF/Serum Ratio to a Biomarker Panel. PLoS One 2015; 10: e0119681 5 Modvig S et al. Cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain predict multiple sclerosis development and disability after optic neuritis. Mult Scler 2015; Feb 19. pii: 6 Teunissen CE, Khalil M. Neurofilaments as biomarkers in multiple sclerosis. Mult Scler 2012; 18: 552-556 7 Gunnarsson M et al. Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab. Ann Neurol 2011; 69: 83-89 8 Kuhle J et al. Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis. Neurology 2015; 84: 1639-1643 9 Disanto G et al. Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome. J Neurol Neurosurg Psychiatry 2015; pii: jnnp-2014-309690 10 Komori M et al. Cerebrospinal fluid markers reveal intrathecal inflammation in progressive multiple sclerosis. Ann Neurol 2015;
